WHO ICTRP trial
to observe the difference between Diosmin (900 mg) with Traneximic acid (500 mg)…
CTRI/2019/11/021844 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2019/11/021844 |
|---|---|
| Public title | to observe the difference between Diosmin (900 mg) with Traneximic acid (500 mg) and Mefanamic acid (250 mg) in reducing menstural blood loss in pateints of Abnormal Uterine Bleeding |
| Scientific title | Efficacy and safety of Diosmin (900 mg) given along with Tranexamic acid (500 mg) and Mefenamic acid (250 mg) in reducing menstural blood loss in patients of Abnormal Uterine Bleeding A Prospective double blind randomized controlled trial(RCT) - NIL |
| Primary sponsor | Walter Bushnell Pvt ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: N920- Excessive and frequent menstruation with regular cycle |
| Interventions | Intervention1: Group 2 : In Group 2 A women of age below 30 years and in Group 2 B women of age above 30 to 45 years 500 mg traneximic acid, thrice daily, from day 1 to 5 of the menstrual cycle and Mefenemic acid 250 mg thrice daily, from… |
| Registration date | Jan 11, 2019 |
| Target size | 320 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: